




























0Neuroscience and Biobehavioral Reviews 42 (2014) 267–278
Contents lists available at ScienceDirect
Neuroscience and Biobehavioral Reviews
journa l homepage: www.e lsev ier .com/ locate /neubiorev
eview
he association of the BDNF Val66Met polymorphism and the
ippocampal volumes in healthy humans: A joint meta-analysis of
ublished and new data
. Harrisbergera,b,1, K. Spalekc,1, R. Smieskovaa,b, A. Schmidta,b, D. Coynelc,d, A. Milnikd,
. Fastenrathc, V. Freytagd, L. Gschwindc, A. Waltera, T. Vogela, K. Bendfeldtb,
.J.-F. de Quervaina,c, A. Papassotiropoulosa,d,e, S. Borgwardta,b,f,∗
University of Basel, Department of Psychiatry (UPK), Wilhelm Klein-Strasse 27, 4056 Basel, Switzerland
University Hospital Basel, Medical Image Analysis Center, Schanzenstrasse 55, 4031 Basel, Switzerland
University of Basel, Department of Psychology, Division of Cognitive Neuroscience, Birmannsgasse 8, 4055 Basel, Switzerland
University of Basel, Department of Psychology, Division of Molecular Neuroscience, Birmannsgasse 8, 4055 Basel, Switzerland
University of Basel, Department Biozentrum, Life Science Training Facility, Klingelbergstrasse 50/70, 4056 Basel, Switzerland
King’s College London, Department of Psychosis Studies, Institute of Psychiatry, De Crespigny Park 16, SE5 8AF London, UK
r t i c l e i n f o
rticle history:
eceived 21 November 2013
eceived in revised form 17 February 2014










a b s t r a c t
Background: The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism (refSNP Cluster
Report: rs6265) is a common and functionally relevant single nucleotide polymorphism (SNP). The gene
itself, as well as the SNP rs6265, have been implicated in hippocampal learning and memory. However,
imaging genetic studies have produced controversial results about the impact of this SNP onhippocampal
volumes in healthy subjects.
Methods: We examined the association between the rs6265 polymorphism and hippocampal volume in
643 healthy young subjects using automatic segmentation and subsequently included these data in a
meta-analysis based on published studies with 5298 healthy subjects in total.
Results:Wefoundno signiﬁcant associationbetweenSNP rs6265 andhippocampal volumes in our sample
(g=0.05, p=0.58). The meta-analysis revealed a small, albeit signiﬁcant difference in hippocampal vol-
umes between genotype groups, such that Met-carriers had slightly smaller hippocampal volumes than
Val/Val homozygotes (g=0.09, p=0.04), an association that was only evident when manual (g=0.22,
p=0.01) but not automatic tracing approaches (g=0.04, p=0.38) were used. Studies using manual trac-
ing showed evidence for publication bias and a signiﬁcant decrease in effect size over the years with
increasing sample sizes.
Conclusions: This study does not support the association between SNP rs6265 and hippocampal volume
in healthy individuals. The weakly signiﬁcant effect observed in the meta-analysis is mainly driven by
studies with small sample sizes. In contrast, our original data and the meta-analysis of automatically
segmented hippocampal volumes, which was based on studies with large samples sizes, revealed no
signiﬁcant genotype effect. Thus, meta-analyses of the association between rs6265 and hippocampal
volumes should consider possible biases related to measuring technique and sample size.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
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. Introduction
Brain-derived neurotrophic factor (BDNF) – a member of the
erve growth factor family – plays an important role in neurogen-
sis and is implicated in several molecular processes in the central
ervous system (Barde et al., 1982; Lu and Gottschalk, 2000; Park
nd Poo, 2013). BDNF is highly expressed in the hippocampus, a key
egion for adult neurogenesis (De Quervain and Papassotiropoulos,
006; Milner et al., 1998), and is thought to be involved in learning
nd memory (Cunha et al., 2010). Pro-BDNF can induce apoptosis,
hile mature BDNF predominantly mediates cell survival and neu-
onal differentiation (Panget al., 2004;Korte et al., 1995; Pastalkova
t al., 2006). The single nucleotide polymorphism (SNP) rs6265
t codon 66 of the BDNF gene predicts a valine (Val) to methi-
nine (Met) substitution in the pro-region of the protein, which
s important for proper BDNF sorting. The Val66Met substitution
as been investigated in a transgenic mouse model of defective
DNF secretion in hippocampal neurons (Chen et al., 2004; Egan
t al., 2003). BDNF Met/Met mice have smaller hippocampal vol-
mes, less dendritic arbor complexity of hippocampal neurons
nd impaired synaptic plasticity, as indicated by a decrease in
MDA-receptor-dependent long-term depression and long-term
otentiation (Chen et al., 2006; Ninan et al., 2010).
Defects in synaptic plasticity and long-term potentiation, core
echanismsofhippocampus-dependent learning andmemory, are
hought to underlie – at least in part – neurocognitive impairments
n a broad spectrum of neuropsychiatric disorders (Fusar-Poli
t al., 2012; Lu et al., 2013). Another characteristic of neuropsychi-
tric disorders, such as schizophrenia, bipolar disorder, depression,
ost-traumatic stress disorders and personality disorders, is the
eduction in hippocampal volume (Geuze et al., 2005; Smieskova
t al., 2010; Walter et al., 2012). It is still not clear to what extent
hese hippocampal volume abnormalities are driven by genetic
iability (Sullivan et al., 2003). One putative genetic risk factor
f these alterations might be the BDNF polymorphism described
bove (Boulle et al., 2012; Frielingsdorf et al., 2010). The effect
f this polymorphism has often been studied in healthy subjects,
ecause in ahealthypopulation, changes in brain volumes are inde-
endent of effects of illness or medication, and of disease-related
enetic risk factors (Fusar-Poli et al., 2013; Smieskova et al., 2009).
To date ﬁndings from structural magnetic resonance imag-
ng (sMRI) studies investigating genotype-dependent association
f rs6265 SNP on hippocampal volumes are inconsistent. While
hree recent meta-analyses report that Met-carriers have smaller
ippocampal volumes than Val/Val homozygotes (Hajek et al.,. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 276
2012; Kambeitz et al., 2012; Molendijk et al., 2012a), the relation
between rs6265 and hippocampal volumes is confounded by sev-
eral problems: Firstly, two of these studies (Kambeitz et al., 2012;
Molendijk et al., 2012a) included a variety of neurocognitive disor-
ders, suggesting that hippocampal volumeswere probably affected
by burden of illness, medication or comorbid conditions and were
not necessarily related to the SNP per se. Secondly, all of these
meta-analyses incorporated studies with children/adolescents and
elderly subjects. This can be critical, as hippocampal volumes
undergo age-related changes (Karnik et al., 2010; Walhovd et al.,
2011; Goodro et al., 2012). Finally, although one of the previous
meta-analyses focuses exclusively on healthy subjects (Hajek et al.,
2012), the analysis in this study was restricted to manual tracing
of hippocampal volumes without considering automatic measure-
ment techniques.
The present study aimed to control for these confounding fac-
tors. First, we assessed the association between the BDNF rs6265
polymorphism and hippocampal volumes using the automated
tracing technique in 643 healthy young volunteers. Because the
effect size of this association is known to be small (Kambeitz et al.,
2012; Molendijk et al., 2012a), we then increased statistical power
by means of meta-analytic techniques (Kim-Cohen et al., 2006;
Munafò et al., 2009; Brandys et al., 2011).We therefore performed a
systematic review of the hippocampal volumes in healthy subjects
genotyped for SNP rs6265 and combined these data with our origi-
nal results in a meta-analysis. Additionally, we examined the effect
of potential moderators such as measuring technique, MR mag-
netic ﬁeld strength, age, gender, ethnicity, Val/Met ratio, sample
size, quality rating, hippocampal volumes normalized to intracra-
nial volume (ICV), and publication year.
2. Material and methods
2.1. Original data of 643 healthy subjects
2.1.1. Participants
We recruited 643 healthy young subjects (383 women;
age range 18–35 years, mean age± standard deviation (SD)
22.87±3.22). Participants ﬁlled in a self-rating questionnaire con-
cerning their health status, medication, and drug consumption.
All included subjects were free of any physical, neurological or
psychiatric illness, and were taking no medication. 87% of the sub-
jects were students and 91% were right-handed (see Table 1). The
ethics committee of the Canton of Basel approved the experiments.
F. Harrisberger et al. / Neuroscience and Biobehavioral Reviews 42 (2014) 267–278 269
Table 1
Overview of included subjects.




Statistics p-Value Effect size*
Age [mean± SD] 22.75±3.22 413 23.10±3.23 230 F=1.72 df =1 0.19 0.003
Sex
Women 254 129 x2 = 1.80 0.18 0.053
Men 159 101 df =1
Profession
In education 361 198 x2 = 0.69 0.71 0.033
Working 35 24 df =2













































relation between the SNP rs6265 and sMRI, (c) showing hippocam-
pal data. A total of 27 publications met these criteria, whereof
from one recent genome-wide association study (GWAS) data of
5 cohorts were obtained (Stein et al., 2012). Altogether a totalRight 376
Left 37
* Partial eta (2) is reported for age differences, whereas Cramers V is indicated f
ritten informed consent was obtained from all subjects prior to
articipation.
.1.2. Genotyping
DNA was extracted from saliva samples collected with the Ora-
ene DNA sample collection kit using standard procedures (DNA
enotek Inc., Ontario, Canada). DNA sampleswereprocessedon the
ffymetrix® Genome-Wide Human SNP Array 6.0. in one central-
zed microarray facility. rs6265 (refSNP Cluster Report: rs6265) is
epresentedon thearray (AFFY|SNP A-2038925).Generationof SNP
alls and arrayquality controlwereperformedusing theAffymetrix
enotypingConsole Software3.0 (Affymetrix Inc.). According to the
anufacturer’s recommendation, contrast quality control (QC)was
hosenasQCmetric, using thedefault valueof 0.4. All samplespass-
ng QC criteria were subsequently genotyped using the Birdseed
v2) algorithm. Genotypic outliers were identiﬁed using Bayesian
lustering algorithm (Bellenguez et al., 2012) and excluded (for
ore details see supplementary material).
.1.3. Image acquisition and extraction of hippocampal volumes
We acquired an anatomical sequence with a radio-frequency
ulses and rapid gradient-echo (MPRAGE) sequence. For this
equence, we used the following acquisition parameters: TE
echo time) =3.37ms, FOV (ﬁeld of view) =25.6 cm, acquisition
atrix =256×256×176, voxel size: 1mm×1mm×1mm. Using
midsaggital scout image, 176 contiguous axial slices were placed
long the anterior–posterior commissure (AC–PC) plane covering
he entire brain with a TR=2000ms ( =8 degrees).
Segmentations of cortical and subcortical structures were
etrieved from FreeSurfer 4.5 and labeling was based on the
esikan–Killiany Atlas (Desikan et al., 2006). We extracted raw
olumes for both hippocampi for n=805 subjects. Left and right
ippocampal volumes were corrected separately for ICV, age, sex
nd differences due to software and gradient updates by using the
-transformed residuals of a linear regression. Afterwards we did
separate outlier-control for both hippocampal sides (mean±3.5
D). For all subjects with complete dataset, we then calculated the
orrectedmeanvalueof bothhippocampal volumes. For a subgroup
f n=643 subjectswehad additional genetic information regarding
DNF genotype. The corrected volumetric data of these subjects
ere included in all further analyses.
.1.4. Association analysis
For the genetic association analysis, we used the WG-Permer
oftware (www.wg-permer.org), with analysis of variance for
uantitative phenotypes. This software corrects nominal p-values
or multiple testing on a permutation-based procedure according
o Westfall and Young (Westfall, 1993).
One-way analyses of variance (ANOVA) and chi-square tests
ere used to test for differences between genotype groups of age,210 x2 = 0.01 0.91 0.004
20 df =1
, profession and handedness differences.
sex, profession and handedness. These statistical analyses were
performedwith SPSS (IBMSPSS Statistics, Version 20, 2011). Values
are presented as mean± SD (see Table 1).
2.2. Meta-analysis
2.2.1. Literature search and inclusion criteria
Electronic searches were conducted using PubMed and Embase,
considering all publications until the end of December 2012 with
the following search terms: “BDNF Val66Met” AND “MRI” and
“rs6265” AND “MRI”. Additionally, a retrospective search was
carried out on the reference lists of the included articles. This
resulted in 86 publications, for which the abstracts were screened
(more information is presented in Fig. 1). In this meta-analysis,
we included healthy groups only. Firstly, we extracted studies
addressing the relation between hippocampal volumes and the
SNP. Secondly, the papers were ﬁltered according to the following





























































homozygous 0.041±0.97 (n=413), Met-carriers 0.023±1.01
(n=230); p=0.15, see Fig. 2). The difference between genotypes in
mean hippocampal volumes resulted in a non-signiﬁcant g of 0.05
(p=0.58).Wedidnotobserveamaineffect of ageor sexaswell asno70 F. Harrisberger et al. / Neuroscience an
f 32 samples, 31 previously published and our own data, were
ncluded in this meta-analysis. Criteria for exclusion were: mean
ge of participants (<15 or >65 years), not clearly deﬁned healthy
ontrol group, overlapping datasets, and only left or only right
ippocampal volume reported. The authors were contacted when
nformation essential for the calculation of effect sizes was miss-
ng. Bothmeasuring techniques, i.e. automated andmanual tracing,
ere included.We followed the ‘Preferred Reporting Items for Sys-
ematic Reviews and Meta-Analyses’ (PRISMA) guidelines (Moher
t al., 2010).
.2.2. Data extraction
The following variableswere extracted: First author name, pub-
ication year, number of independent samples per study. For each
ndependent sample, we extracted sample size of genotype sub-
roups, ethnicity, gender, mean age of sample, Hardy–Weinberg
quilibrium (HWE; calculated, when not reported), genotyping
ethod, structuralMRImeasurement technique, directionof effect,
eld strength of MR scanner, mean hippocampal volumes and
tandard deviation, t-statistic, F-statistic and p-values per geno-
ype, and whether the hippocampal volumes were normalized to
CV. To sustain statistical independence, one single effect size per
ample was used for this meta-analysis.
.2.3. Quality assessment
Using an 11-item checklist adapted from (Karg et al., 2011) the
uality of the included studies was evaluated. In detail, the crite-
ia were: (1) Funding – role in analysis and interpretation of data,
2) Sample size, (3) Clear inclusion criteria for participants, (4)
eported allele distribution, (5) Ethnicity assessed, (6) Ifmixed eth-
icity:discussionofproblems, (7) IQ/educational level available, (8)
nter- and intrarater reliability, (9) Report of HWE, (10) Sample in
WE and (11) Additional descriptive data including age, gender,
enotyping method, magnetic ﬁeld strength of scanner. For each
ategory 0, 1 or 2 points were given. Finally, the included studies
ere rated according to the sum of the points and characterized as
igh (above 80% of the maximal sum of points), moderately high
60–79%), moderate (40–59%), moderately low (20–39%), and low
uality studies (below 19%) (for more details see supplementary
ables S1 and S2).
.2.4. Data analysis
Data were entered into an electronic database and quantitative
eta-analysis was performed using the R 2.15.2 software (R Core
eam, 2012). The effect size was calculated using Hedge’s g, which
rovides an unbiased standardized mean difference that incorpo-
ates a correction for small sample sizes (Lipsey and Wilson, 2000).
edge’s gvalues above0.2, 0.5 and0.8 correspond to small,medium
nd large effect sizes respectively. Hedge’s g was calculated using
ata of mean hippocampal volumes, standard deviations and sam-
le sizes. Where these data were not available, we employed the
-statistic, F-statistic or p-values, together with the correspond-
ng sample sizes. A positive value of the effect size reﬂected larger
ippocampal volumes in theVal/Val homozygotes than for theMet-
arriers of the SNP rs6265. We employed a random-effects model
ith the DerSimonian-Laird estimator using the metafor package
DerSimonian and Laird, 1986; Wolfgang Viechtbauer, 2010). The
andom-effects model shows more ﬂexibility with respect to effect
ize variability between studies and study populations (Cooper
t al., 2009), as it incorporates the between-study variance 2. And
n case of high between-study heterogeneity, the random-effects
odel compared to the ﬁxed-effects model is the model of choiceIoannidis et al., 2007).
Cochran’s Q test was then used to calculate between-group het-
rogeneity; the magnitude of heterogeneity was assessed by I2
Higgins andThompson, 2002). I2 is an estimate of variability acrossehavioral Reviews 42 (2014) 267–278
studies based on heterogeneity rather than chance, ranging from 0
to 100%. Values above 25%, 50% and 75% corresponded to low,mod-
erate and high heterogeneity respectively (Higgins and Thompson,
2002). Furthermore, potential publication bias was investigated by
funnel plot asymmetry and Egger’s regression test (Egger et al.,
1997). In case of a bias, “the trim and ﬁll” method was used sub-
sequently to identify and correct for publication bias detected by
an asymmetric funnel plot (Duval and Tweedie, 2000). A series of
meta-regression analyses was carried out to assess the impact of
possibly moderating study design characteristics such as publica-
tion year, age of participants, gender ratio, ethnicity, Val/Met ratio,
sample size, quality rating, magnetic ﬁeld strength, hippocampal
volumes normalized to intracranial volume and applied hippocam-
pal measuring techniques. Most studies used a dominant allele
approach, but two studies reported an additive allele comparison
(Agartz et al., 2006; Gruber et al., 2012). Nevertheless, these were
treated equivalently in this analysis.
3. Results
3.1. Association analysis of 643 healthy subjects
Of the 643 subjects, 413 were homozygous for the Val allele,
204 were heterozygous Val/Met, and 26 were homozygous for Met
allele. Met-carriers were taken together in a single group. Geno-
type groups did not differ according to age, sex, profession and
handedness (see Table 1). All 643 subjects had complete genotype
information. The genotype distribution did not deviate from the
Hardy–Weinberg equilibrium (p=0.90).
As shown in Fig. 2, there were no signiﬁcant genotype-
dependent differences in the z-transformed scores of the
left (Val/Val homozygous 0.029±0.97 (n=413), Met-carriers
0.001±0.98 (n=230); p=0.25, see Fig. 2), right (Val/Val homozy-
gous 0.048±0.96 (n=413), Met-carriers 0.043±1.05 (n=230);
p=0.12, see Fig. 2) and mean hippocampal volume (Val/ValFig. 2. Barplot showing left, right and mean bilateral hippocampal volumes
[mm3]± standard deviation of our original data. Neither the left, right nor mean
bilateral hippocampus showed a signiﬁcant difference between 230 Met-carriers
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nteraction effect of sex and rs6265 genotype groups on hippocam-
al volumes (see supplementarymethods and supplementary table
3).
.2. Description of studies and cohorts included in the
eta-analysis
A total of 4655 subjects in 32 datasets were selected for this
andom-effects meta-analysis (Agartz et al., 2006; Bueller et al.,
006; Cerasa et al., 2010; Chepenik et al., 2009; Cole et al., 2011;
utt et al., 2009; Frodl et al., 2007; Gatt et al., 2009; Gonul et al.,
011; Gruber et al., 2012; Jessen et al., 2009; Joffe et al., 2009;
oolschijn et al., 2010;Molendijk et al., 2012b;Montag et al., 2009;
emoto et al., 2006; Pezawas et al., 2004; Richter-Schmidinger
t al., 2011; Sanchez et al., 2011; Schoﬁeld et al., 2009; Smith et al.,
012; Soliman et al., 2010; Stein et al., 2012; Stern et al., 2008;
zeszko et al., 2005; Takahashi et al., 2008; Yang et al., 2012).
ll 27 included studies were published between 2004 and 2012.
his structuralMRImeta-analysis comprises 1771Met-carriers and
884 Val/Val homozygotes. For an overview of all included sam-
les, see Table 2. Ethnicity was reported in 26 samples, of which
9 were performed on a Caucasian sample, 2 on a Japanese sam-
le, 1 on a Chinese sample and 4 on a sample of mixed ethnicity.
he overall mean age of all datasets providing this information was
1.65±9.0. The Hardy–Weinberg equilibrium did not deviate in 28
atasets, whereas in 3 datasets this parameter could not be calcu-
ated due to insufﬁcient data. Quality analysis showed that most of
he included studies were of high or moderate quality (44% high
nd 48% moderate scores, supplementary table S1 and table S2).
.3. Meta-analysis of one original and 31 previously published
amples
Meta-analysis of all datasets (k=32) showed evidence for sig-
iﬁcant, albeit weak association between hippocampal volumes
nd SNP rs6265 (g=0.09, se =0.04, 95% CI = [0.01–0.17], Z=2.08,
= 0.0376, see Fig. 3A and table S4), with indications of signiﬁ-
ant between-study heterogeneity (I2 =38.24%, Q(df =31) =50.20,
= 0.02). The effect was in the direction of slightly smaller hip-
ocampal volumes for Met-carriers than for Val/Val homozygotes.
isual inspection of the funnel plot indicated evidence for poten-
ial publication bias (Fig. 3B, table S4). This was quantitatively
onﬁrmed by signiﬁcant regression intercept in Egger’s regres-
ion test (p=0.0075). The trim and ﬁll procedure suggested 8
issing studies on the left side of the funnel plot and a cor-
ected non-signiﬁcant Hedge’s g of 0.02 (95% CI = [−0.07–0.11],
ig. 3B). Meta-regression analysis did not reveal any effect for
ge of participants (ˇ =−0.08, F(1,30) =0.18, p=0.67), gender ratio
ˇ =0.13, F(1,30) =0.48, p=0.49), ethnicity of the subjects (ˇ =0.26,
(1,25) =1.83, p=0.19), Val/Met ratio (ˇ =0.14, F(1,24) =0.48,
= 0.50), sample size (ˇ =−0.23, F(1,30) =1.71, p=0.20), quality
ating (ˇ =−0.32, F(1,24) =2.74, p=0.11), magnetic ﬁeld strength
ˇ =−0.22, F(1,28) =1.49, p=0.23), or hippocampal volumes nor-
alized to ICV (ˇ =−0.01, F(1,30) =0.002, p=0.96). However, the
nalysis of the meta-regressions indicated a potential source for
ias related to measurement techniques (ˇ =0.43, F(1,29) =6.55,
= 0.02) (see Fig. 3C and table S4) andyear of publication (ˇ =−0.38,
(1,30) =5.01, p=0.03) (see Fig. 3A, cumulative meta-analysis, and
able S4).
.4. Effect of moderatorsTo further disentangle the moderating effect of the mea-
urement technique, samples were subsequently subdivided into
anually and automatically segmented volumes of the hip-
ocampi. One study using semi-automated analysis was excludedehavioral Reviews 42 (2014) 267–278 271
fromfurther analysis (Sanchezet al., 2011), leaving13 sampleswith
manual tracing (n=829 subjects) and 18 samples using automated
segmentation (n=4426 subjects). The detected small effect size
estimate of manual tracing samples indicated signiﬁcantly smaller
hippocampal volumes for Met-carriers compared to Val/Val sub-
jects (g=0.22, se =0.09, 95% CI = [0.05–0.39], Z=2.51, p=0.0121,
I2 =38.12%,Q(df = 12) =19.39, p=0.08, Trim and ﬁll: 5missing stud-
ies on left side of the funnel plot and a corrected non-signiﬁcant g
of 0.08, see Fig. 4A and table S4). The meta-analysis of the manual
tracing samples revealed signiﬁcant publication bias (Egger’s test:
z=3.24, p=0.0012), signiﬁcant between-study heterogeneity and
a signiﬁcant moderator effect only for the sample size (ˇ =−0.72,
F(1,11) =12.07, p=0.01). Analysis of the relation between years of
publication and effect size revealed a signiﬁcant decrease in the
effect sizes with increasing sample size over the years, but only
for manual tracing samples (see Fig. 5). In contrast, the overall
effect size of the samplesusing automaticmeasurement techniques
showed no signiﬁcant genotype effect (g=0.04, se =0.05, 95%
CI = [−0.05–0.13], Z=0.89, p=0.3751, I2 =37.87%, Q(df = 17) =27.36,
p=0.05, see Fig. 4B and table S4).
4. Discussion
In this paper, we present a joint analysis of the relation
between the BDNF SNP rs6265 and the hippocampal volumes in
healthy young subjects. Speciﬁcally, we ﬁrst exploredwhether hip-
pocampal volumes of 643 healthy individuals differed between
Val/Val homozygotes and Met-carriers. These data were further
incorporated into a meta-analysis of previously published studies
subsuming a total of 5298 healthy subjects.
Hippocampal volume is a heritable quantitative trait (estimates
vary between 40 and 69%). Hence, several studies have analyzed
the association between candidate genes, such as BDNF, and the
hippocampus (Goldman et al., 2008; Peper et al., 2007; Sullivan
et al., 2001). However, the studies investigating the association
betweenBDNFSNP rs6265andhippocampal volumes report incon-
sistentﬁndings. SomestudiesobserveBDNF-dependentdifferences
in hippocampal volumes (Bueller et al., 2006; Montag et al., 2009;
Pezawas et al., 2004; Schoﬁeld et al., 2009), whereas others do not
ﬁnd an association (Agartz et al., 2006; Cerasa et al., 2010; Chepenik
et al., 2009; Cole et al., 2011; Dutt et al., 2009; Frodl et al., 2007;
Gatt et al., 2009; Gruber et al., 2012; Jessen et al., 2009; Joffe et al.,
2009; Koolschijn et al., 2010;Molendijk et al., 2012b; Nemoto et al.,
2006; Richter-Schmidinger et al., 2011; Sanchez et al., 2011; Smith
et al., 2012; Soliman et al., 2010; Stein et al., 2012; Stern et al., 2008;
Szeszko et al., 2005; Takahashi et al., 2008; Yang et al., 2012). The
results based on our own data as well as the meta-analysis across
studies applying automatic hippocampal segmentation do not sup-
port an association between rs6265 and hippocampal volumes.
Several studies report BDNF-dependent volume differences in
the hippocampus of patients with neuropsychiatric disorders such
as bipolar disorder and schizophrenia (Chepenik et al., 2009;
Szeszko et al., 2005) as well as between healthy controls and
patients of the same genotype (Chepenik et al., 2009; Gonul et al.,
2011; Koolschijn et al., 2010; Smith et al., 2012). Other studies
in patient populations found no association of the rs6265 poly-
morphism and hippocampal volumes (Agartz et al., 2006; Cerasa
et al., 2010; Cole et al., 2011; Dutt et al., 2009; Frodl et al., 2007;
Gruber et al., 2012; Jessen et al., 2009; Molendijk et al., 2012b;
Takahashi et al., 2008). Two recent meta-analyses did not ﬁnd a
signiﬁcant association of SNP rs6265 and hippocampal structure in
neuropsychiatric disorders, including schizophrenia, bipolar dis-
order, depressive and anxiety disorders (Kambeitz et al., 2012;
Molendijk et al., 2012a). However, themeta-analyseswere not con-















Overview of included imaging genetics samples.












Direction of effect Hippocampal
measuring
technique
Agartz et al. (Agartz
et al., 2006)
2006 104 41.6 ± 8.9 35/69 4 27 73 y◦ Pyrosequencing + 1.5 T Met/Met <Val/Met <Val/ValManual tracing
Bueller et al. (Bueller
et al., 2006)
2006 36 27.1 ± 6.6 22/14 0 15 21 y◦ PCR-RFLP + 1.5 T Met/Val <Val/Val Manual tracing
Cerasa et al. (Cerasa
et al., 2010)




2009 18 28 ± 12 12/6 0 6 12 y◦ TaqMan − 1.5 T Met-carriers <Val/Val Manual tracing
Cole et al. (Cole et al.,
2011)
2011 109 33.0 ± 9.2 54/55 4 37 68 y PCR-RFLP or
TaqMan
+ 1.5 T Met-carriers >Val/Val Manual tracing
Dutt et al. (Dutt et al.,
2009)
2009 60 40.8 ± 15.1 33/28 – 17 43 y SNuPe
technology
− 1.5 T Met-carriers <Val/Val Manual tracing
Frodl et al. (Frodl et al.,
2007)
2007 60 41.6 ± 12.3 29/31 1 19 40 y RT-PCR − 1.5 T Met-carriers <Val/Val Manual tracing
Gatt et al. (Gatt et al.,
2009)
2009 89 36.2 ± 12.7 28/61 – 26 63 y PCR-RFLP − 1.5 T Met-carriers >Val/Val SPM2: VBM: ROI
Gonul et al. (Gonul
et al., 2011)
2011 40 29.8 ± 6.4 17/23 0 16 24 y RT-PCR − 1.5 T Met-carriers <Val/Val Manual tracing
Gruber et al. (Gruber
et al., 2012)
2012 39 38.2 ± 12.8 * 49/57 * 3 12 24 y PCR-RFLP + 1.5 T Met/Met >Val/Met >Val/ValManual tracing
Jessen et al. (Jessen
et al., 2009)
2009 84 43.9 ± 8.7 40/44 – 29 55 ? TaqMan − 1.5 T and 3T Met-carriers <Val/Val Manual tracing
Joffe et al. (Joffe et al.,
2009)




2010 90 38.2 ± 13.6 34/56 5 26 59 y Illumina Bead
Array
− 1.5 T Met-carriers >Val/Val Manual tracing
Millan Sanchez et al.
(Sanchez et al., 2011)
2011 43 57.0 ± 0.9 * 22/122 * – 19 24 ? Illumina Bead
Array






2012 31 37.4 ± 10.1 * 100/57 * 0 10 21 y◦ Four
genotyping
array
− 3.0 T Met/Val <Val/Val SPM5: VBM: ROI
Montag et al. (Montag
et al., 2009)
2009 87 23.9 ± 4.8 63/24 6 27 54 y RT-PCR + 1.5 T Met-carriers <Val/Val SPM5: VBM: ROI
Nemoto et al. (Nemoto
et al., 2006)
2006 109 36.2 ± 12.1 71/38 17 51 41 y TaqMan − 1.5 T Met-carriers <Val/Val SPM2: VBM: ROI
Pezawas et al.
(Pezawas et al., 2004)






































2009 161 32.6 ± 13 75/106 6 59 96 y PCR-RFLP − 1.5 T Met-carriers <Val/Val SPM2: VBM:
whole brain
Smith et al. (Smith
et al., 2012)
2012 39 21.2 ± 4.6 19/20 8 10 21 y TaqMan − 1.5 T Met-carriers <Val/Val FreeSurfer: ROI
Soliman et al. (Soliman
et al., 2010)
2010 70 24.9 ± 4.6 34/36 3 32 35 y◦ TaqMan + 3.0 T Met-carriers >Val/Val FreeSurfer: ROI
Stern et al. (Stern et al.,
2008)
2008 50 31.7 ± 10.5 17/33 0 12 38 y◦ TaqMan + 3.0 T Met/Val <Val/Val FreeSurfer: ROI
Szeszko et al. (Szeszko
et al., 2005)




2008 29 24.2 ± 6.1 12/17 5 11 13 y PCR-RFLP + 1.5 T Met-carriers <Val/Val Manual tracing
Yang et al. (Yang et al.,
2012)
2012 61 20.5 ± 0.9 * 27/34 17 29 15 y PCR-
Sequencing
− 3.0 T Met-carriers <Val/Val FSL-VBM
BFS cohort (Stein et al.,
2012)
2012 220 24.0 ± 7.7 115/105 6 82 132 y Illumina Omni
Express
− 1.5 T Met-carriers >Val/Val FSL FIRST
BIG cohort (Stein et al.,
2012)
2012 1281 22.8 ± 3.3 * 735/546 62 411 808 y Affymetrix
microarray
− 1.5 T and 3T Met-carriers >Val/Val FSL FIRST
MooDS cohort (Stein
et al., 2012)
2012 221 33.1 ± 10.0 119/102 – 81 140 y Illumina
Human610-
Quad
− 3.0 T Met-carriers >Val/Val FreeSurfer
TOP cohort (Stein et al.,
2012)
2012 190 35.8 ± 9.7 91/99 8 55 127 y Affymetrix
Human SNP 6.0
− 1.5 T Met-carriers >Val/Val FreeSurfer
QTIM cohort (Stein
et al., 2012)
2012 811 23.1 ± 2.8 506/305 37 254 520 y Illumina 610K − 4.0 T Met-carriers <Val/Val FSL FIRST
HWE, Hardy–Weinberg equilibrium; ICV, intracranial volume; Met, methionine, ROI, region of interest; Val, valine; VBM, voxel-based morphometry; association study cohorts included in Stein et al. (34): BFS, Bipolar Family
Study; BIG, Brain Imaging Genetic Study; MooDS, Mood Disorders and Schizophrenia; TOP, Thematically Organized Psychosis Study; QTIM, Queensland Twin Imaging Measures; *, reported of larger sample only; ?, not possible
to calculate;◦ , calculated of raw data.
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Fig. 3. (A) Forest plots of random-effects meta-analysis assessing hippocampal volumes with structural MRI and the BDNF SNP rs6265. Positive effect sizes indicate larger
hippocampi in the Val allele subjects than with the Met allele subjects. The forest plot of a cumulative meta-analysis shows the change of the evidence over time. Dashed
l ere w










(ines indicate zero line. (B) Funnel plot with additional trim and ﬁll procedure wh
eta-regression analysis of the hippocampal measuring technique and the effect o
ffects may have inﬂuenced the hippocampal volumes (Fusar-Poli
t al., 2013).
Inconsistent ﬁndings in studies of healthy subjects and psy-
hiatric patients raise the question if BDNF-dependent structural
ippocampal differences are speciﬁc for different developmental
tages. Until now, only few studies have addressed this issue by
nvestigating the relationship betweenBDNF andhippocampal vol-
mes in neonates, children and adolescents and also elderly. Two
tudies have not observed BDNF-dependent differences in hip-
ocampal volumes in children and adolescents (age range 8–19)
Mueller et al., 2013; Toro et al., 2009). In contrast, Knickmeyerhite dots indicate the missing studies to correct for potential publication bias. (C)
NP rs6265, MT: manual tracing, AM: automatic measurement.
and colleagues ﬁnd rs6265-dependent differences in hippocam-
pal volumes in neonates (Knickmeyer et al., 2013). However, in
order to investigate the inﬂuence of developmental stages on
BDNF-dependent effects, additional longitudinal studies will be
necessary. For instance, Knickmeyer and colleagueswill implement
a follow-up design, collecting data over several time points (at age
1, 2, 4 and 6 years of age) (Knickmeyer et al., 2013). Moreover,
several studies report hippocampal volume reductions in aging
(Driscoll et al., 2003; Erickson et al., 2010; Malykhin et al., 2008;
Raz et al., 2010). Erikson and colleagues investigated the relation-
ship between serum BDNF levels, age, hippocampal volume and























hig. 4. Forest plots of BDNF SNP rs6265 of structural MRI studies assessing potenti
raced hippocampus; (B) Hippocampus volumes evaluated by automatic measurem
o the Met-carriers. Dashed lines indicate zero line.
emory performance (Erickson et al., 2010). Age was associated
ith reducedhippocampal volumes aswell as reducedBDNF serum
evels and poorer memory performance. In his review, Von Bohlen
nd Halbach suggests a role of BDNF in age-dependent processes
n the hippocampus (Von Bohlen und Halbach, 2010). However,
tudies investigating the association of rs6265 with hippocam-
al volumes in also aged populations report inconsistent results
Brooks et al., 2014; Karnik et al., 2010; Sanchez et al., 2011).
The importance of the hippocampus in learning and memory is
ell established (Squire and Wixted, 2011) and it has been sug-
ested that BDNF plays a role in these processes (Baj et al., 2013;
unha et al., 2010). Even though we did not ﬁnd BDNF-dependent
ifferences in hippocampal volumes, the absence of difference on
he anatomical level does not rule out that BDNF modulates other
rocesses in the hippocampus. Indeed, two studies included in this
eta-analysis provide support for BDNF-dependent differences in
ig. 5. Scatter plot showing the relation between effect size and year of publication
or the association of the hippocampal volume and BDNF SNP rs6265. The size of the
hapes indicates the sample size of each study. Squares represent the studies that
raced the hippocampus manually; circles represent the studies that measured the
ippocampus automatically. Dashed line indicates zero line.lication bias arising from the applied hippocampus analysis technique. (A) Manual
ositive effect sizes indicate larger hippocampi in the Val allele subjects compared
hippocampal activation during memory paradigms in the absence
of structural differences (Cerasa et al., 2010; Molendijk et al.,
2012b), which is further supported by additional studies analyzing
functional MRI data (Dennis et al., 2011; Egan et al., 2003; Hariri
et al., 2003; Hashimoto et al., 2008). However, the meta-analysis
by Kambeitz and colleagues did not ﬁnd an association between
rs6265 and hippocampus-mediated memory activation, which
might be explained by the large variety of paradigms combining
working and episodic memory processes (Kambeitz et al., 2012).
Moreover, meta-analyses assessing an association between rs6265
and declarative memory performance revealed contradictory
results (Kambeitz et al., 2012; Mandelman and Grigorenko, 2012).
In our meta-analysis we observed an effect of the applied mea-
suring technique (manually traced vs. automatically measured
hippocampal volumes) after we investigated the effect of sev-
eral moderators due to signiﬁcant between-study heterogeneity
and publication bias. First, the overall meta-analysis showed a
weakly (g=0.09) signiﬁcant association between hippocampal vol-
umes and SNP rs6265. In particular, Val/Val homozygotes had
signiﬁcantly larger hippocampal volumes than Met-carriers. The
direction of the effect is in accordance with recent meta-analyses
of healthy subjects (Hajek et al., 2012; Kambeitz et al., 2012;
Molendijk et al., 2012a), but the effect size in this studywas consid-
erably smaller. To further disentangle the dissociable effect of these
two measurement approaches, subsequent analyses were con-
ductedafter separating the samplesby thehippocampusmeasuring
technique. We found that Met-carriers had smaller hippocampal
volumes thanVal/Val homozygotes (g=0.22)when thehippocampi
were manually segmented. In contrast, we did not ﬁnd a signiﬁ-
cant genotype effect with automatic segmentation (g=0.04). This
latter result is consistent with the ﬁndings of our original sample
in 643 healthy subjects, where we used the automatic segmenta-
tion technique from FreeSurfer and also with the results of a recent
GWAS analysis in 5776 healthy subjects (Stein et al., 2012). Even
though manual segmentation is generally considered as the gold
standard due to the precise delineation of anatomical structures,
the increasing sample size of imaging studies renders the pro-
cess of manual segmentation less practicable, as it is both costly
and time consuming. Several studies compared manual and dif-
ferent automatic segmentation methods and report comparable
accuracy, sensitivity and reproducibility (Bergouignan et al., 2009;






























































K.S., 2011. Brain-derived neurotrophic factor val66met polymorphism and hip-
pocampal activation during episodic encoding and retrieval tasks. Hippocampus76 F. Harrisberger et al. / Neuroscience an
peciﬁcally, automated segmentation of the hippocampus using
reeSurfer shows higher correlations with manual segmentation
ompared to FSL/First (Doring et al., 2011; Morey et al., 2009).
onetheless, it has been shown that, compared to manual seg-
entation, FreeSurfer and FSL overestimate hippocampal volumes
Doring et al., 2011; Morey et al., 2009) while they are under-
stimated by SACHA (Bergouignan et al., 2009). However, our
eta-analysis across studies using only manual tracing samples
evealed a publication bias, between-study heterogeneity and a
oderator effect for the sample size. These effects were further
tudied in detail to investigate the relation between sample size
nd publication year. We showed that effect sizes shrink as a func-
ion of publication year and sample size. In contrast to the ﬁndings
f previous meta-analyses (Kambeitz et al., 2012; Molendijk et al.,
012a), this decrease in effect size could not be attributed to pub-
ication year alone, but was also linked to an increase in sample
ize.
Several limitations of our analyses need to be considered. In our
eta-analysis, we could not address laterality differences or differ-
nces in speciﬁc hippocampal sub-regions as many of the included
tudies only report total hippocampal volumes. Furthermore, we
xplicitly focused on the impact of the rs6265 polymorphism on
ippocampal volumes in healthy subjects, without considering the
ffect of other SNPs, gene-gene interactions (Honea et al., 2009)
r gene-environment interactions (Gatt et al., 2009; Gerritsen
t al., 2012). This is of particular relevance, as the impact of the
DNF SNP rs6265 on hippocampal volume could be modiﬁed by
ther SNPs that have already been shown to impact the volume
f the hippocampus, such as the Val159Met polymorphism of
atecholamine-O-methyltransferase (COMT) (Cerasa et al., 2008;
utt et al., 2009; Ehrlich et al., 2010; Honea et al., 2009; Taylor
t al., 2007), an SNP of ZNF804a (Donohoe et al., 2011; Wei et al.,
012) or the intergenic variant rs7294919 (Stein et al., 2012).
inally, we did not observe a main effect of sex and age on hip-
ocampal volumes, nor did we observe an interaction effect of
ex and genotype on hippocampal volumes. Other studies found
ex- (Cahill, 2006; Goldstein et al., 2001; Liu et al., 2010; Ruigrok
t al., 2013), and age-dependent differences in hippocampal vol-
mes (Driscoll et al., 2003; Malykhin et al., 2008; Raz et al., 2010).
ince the association of rs6265 and age-dependent hippocampal
hanges revealed controversial results (Brooks et al., 2014; Karnik
t al., 2010; Sanchez et al., 2011) and the role of sex in this asso-
iation is not well understood, it would be interesting if future
tudies would address these questions. Potential reasons for the
bsence of such effects in our original study are the applied cor-
ection for intracranial volume and the limited age-range of our
ample.
In summary, the present study does not support the association
etween SNP rs6265 and hippocampal volumes in healthy individ-
als. Theweakeffect observed in themeta-analysis ismainlydriven
y studies with small sample sizes applying manual segmentation
f hippocampi. Our ﬁndings conﬁrm the results of previous results
ased on a large sample size. Moreover, our ﬁndings demonstrate
n effect of measuring techniques, publication year and sample
ize.
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